Inspire Medical Systems, Inc. (INSP)
USD 186.97
(-1.96%)
USD 186.97
(-1.96%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -21.15 Million USD | 52.87% |
| 2022 | -44.88 Million USD | -6.75% |
| 2021 | -42.04 Million USD | 26.5% |
| 2020 | -57.2 Million USD | -72.08% |
| 2019 | -33.24 Million USD | -52.3% |
| 2018 | -21.82 Million USD | -24.65% |
| 2017 | -17.51 Million USD | 5.49% |
| 2016 | -18.52 Million USD | 13.16% |
| 2015 | -21.33 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -10 Million USD | -167.77% |
| 2024 Q2 | 9.79 Million USD | 197.88% |
| 2024 Q3 | 18.49 Million USD | 88.88% |
| 2023 FY | -21.15 Million USD | 52.87% |
| 2023 Q3 | -8.54 Million USD | 28.55% |
| 2023 Q2 | -11.95 Million USD | 22.51% |
| 2023 Q1 | -15.42 Million USD | -589.65% |
| 2023 Q4 | 14.76 Million USD | 272.87% |
| 2022 Q4 | 3.15 Million USD | 118.7% |
| 2022 Q2 | -14.49 Million USD | 13.2% |
| 2022 Q1 | -16.69 Million USD | -598.2% |
| 2022 FY | -44.88 Million USD | -6.75% |
| 2022 Q3 | -16.84 Million USD | -16.27% |
| 2021 Q3 | -10.34 Million USD | 20.94% |
| 2021 FY | -42.04 Million USD | 26.5% |
| 2021 Q1 | -16.21 Million USD | -116.68% |
| 2021 Q2 | -13.08 Million USD | 19.29% |
| 2021 Q4 | -2.39 Million USD | 76.89% |
| 2020 FY | -57.2 Million USD | -72.08% |
| 2020 Q1 | -16.24 Million USD | -78.91% |
| 2020 Q2 | -23.08 Million USD | -42.13% |
| 2020 Q3 | -10.38 Million USD | 55.02% |
| 2020 Q4 | -7.48 Million USD | 27.93% |
| 2019 Q3 | -8.24 Million USD | -7.8% |
| 2019 FY | -33.24 Million USD | -52.3% |
| 2019 Q1 | -8.26 Million USD | -73.0% |
| 2019 Q4 | -9.08 Million USD | -10.1% |
| 2019 Q2 | -7.65 Million USD | 7.45% |
| 2018 Q1 | -6.5 Million USD | -52.93% |
| 2018 Q2 | -5.85 Million USD | 9.92% |
| 2018 Q3 | -4.69 Million USD | 19.86% |
| 2018 Q4 | -4.77 Million USD | -1.81% |
| 2018 FY | -21.82 Million USD | -24.65% |
| 2017 Q1 | -4.48 Million USD | 0.0% |
| 2017 FY | -17.51 Million USD | 5.49% |
| 2017 Q2 | -4.75 Million USD | -6.14% |
| 2017 Q3 | -4.02 Million USD | 15.41% |
| 2017 Q4 | -4.25 Million USD | -5.67% |
| 2016 FY | -18.52 Million USD | 13.16% |
| 2015 FY | -21.33 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Abbott Laboratories | 5.72 Billion USD | 100.37% |
| Allurion Technologies Inc. | -82.3 Million USD | 74.299% |
| Artivion, Inc. | -30.69 Million USD | 31.075% |
| Avanos Medical, Inc. | -61.8 Million USD | 65.772% |
| Butterfly Network, Inc. | -133.69 Million USD | 84.179% |
| Butterfly Network, Inc. | -133.69 Million USD | 84.179% |
| Bio-Rad Laboratories, Inc. | -637.32 Million USD | 96.681% |
| Boston Scientific Corporation | 1.59 Billion USD | 101.328% |
| Perspective Therapeutics, Inc. | -14.67 Million USD | -44.192% |
| CONMED Corporation | 64.45 Million USD | 132.816% |
| Edwards Lifesciences Corporation | 1.4 Billion USD | 101.508% |
| Paragon 28, Inc. | -47.84 Million USD | 55.785% |
| Glaukos Corporation | -134.66 Million USD | 84.292% |
| Globus Medical, Inc. | 122.87 Million USD | 117.215% |
| Integer Holdings Corporation | 90.65 Million USD | 123.335% |
| Medtronic plc | 3.67 Billion USD | 100.575% |
| Nevro Corp. | -92.21 Million USD | 77.061% |
| Owlet, Inc. | -32.9 Million USD | 35.707% |
| Penumbra, Inc. | 90.95 Million USD | 123.257% |
| Vicarious Surgical Inc. | -71.07 Million USD | 70.237% |
| Smith & Nephew plc | 263 Million USD | 108.043% |
| Sonendo, Inc. | -60.91 Million USD | 65.277% |
| STERIS plc | 378.23 Million USD | 105.592% |
| Stryker Corporation | 3.16 Billion USD | 100.668% |
| Vapotherm, Inc. | -58.19 Million USD | 63.65% |
| Zimmer Biomet Holdings, Inc. | 1.02 Billion USD | 102.066% |